Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Other Accumulated Expenses (2016 - 2020)

Phio Pharmaceuticals' Other Accumulated Expenses history spans 8 years, with the latest figure at $104000.0 for Q4 2020.

  • For Q4 2020, Other Accumulated Expenses rose 285.19% year-over-year to $104000.0; the TTM value through Dec 2020 reached $104000.0, up 285.19%, while the annual FY2020 figure was $104000.0, 285.19% up from the prior year.
  • Other Accumulated Expenses reached $104000.0 in Q4 2020 per PHIO's latest filing, up from $27000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $104000.0 in Q4 2020 to a low of $8000.0 in Q4 2017.
  • Average Other Accumulated Expenses over 4 years is $37250.0, with a median of $18500.0 recorded in 2016.
  • Peak YoY movement for Other Accumulated Expenses: fell 20.0% in 2017, then surged 285.19% in 2020.
  • A 4-year view of Other Accumulated Expenses shows it stood at $10000.0 in 2016, then decreased by 20.0% to $8000.0 in 2017, then soared by 237.5% to $27000.0 in 2019, then soared by 285.19% to $104000.0 in 2020.
  • Per Business Quant, the three most recent readings for PHIO's Other Accumulated Expenses are $104000.0 (Q4 2020), $27000.0 (Q4 2019), and $8000.0 (Q4 2017).